Quan Lu receives Tashjian award for excellence in endocrine research at annual ceremony and lecture

Quan Lu
Gökhan S. Hotamisligil, right, with John Lechleiter, president and CEO of Eli Lilly and Company
Gökhan S. Hotamisligil, right, with John Lechleiter, president and CEO of Eli Lilly and Company

May 10, 2013 — Quan Lu, Mark and Catherine Winkler Assistant Professor of Lung Biology in the Departments of Environmental Health and Molecular Metabolism, is the 2013 recipient of the Armen H. Tashjian, Jr. Excellence in Endocrine Research Award. He presented the talk, “Message in a Nano-Vesicle: A New Way of Receptor Signaling and Cell Communication” at the annual award ceremony and lecture on May 1, 2013. The award was presented by Gökhan S. Hotamisligil, J.S. Simmons Professor of Genetics and Metabolism and chair, Department of Molecular Metabolism.

Lu’s work focuses on understanding how complex gene-environment interactions contribute to the development of human diseases. His current research addresses the regulation of cell surface receptors and how environmental exposures perturb receptor signaling and normal physiology.

Amy Tashjian, daughter of Armen Tashjian
Amy Tashjian, daughter of Armen Tashjian

Armen Tashjian was professor of toxicology, emeritus, in the Department of Molecular Metabolism. He led the School’s toxicology program for nearly three decades. The Tashjian Research Award recognizes promising young faculty members and fellows at the School who are pursuing innovative research ideas in basic biomedical sciences.